NCTD can inhibit the tumor vasculogenic mimicry via suppressing MMP-2 expression and blocking the Ephrin Type a Receptor 2/Focal Adhesion Kinase/Paxillin pathway [206, 207]. This evidence concerns the gene MMP2 and neoplasm.